Objectives. Alkaptonuria (AKU) is a genetic disorder caused by lack of the enzyme responsible for breaking down homogentisic acid (HGA), an intermediate in tyrosine metabolism. HGA is deposited as a polymer, termed ochronotic pigment, in collagenous tissues. Pigmentation is progressive over many years, leading to CTDs including severe arthropathies. To investigate the mechanism of pigmentation and to determine how it leads to arthropathy, we aimed to develop an in vitro model of ochronosis.
Introduction
Alkaptonuria (AKU) is a rare inborn error of metabolism with an incidence of approximately 1 in 250 000 people. The highest prevalence is in populations of some parts of Eastern Europe, where it occurs at 1 case per 25 000 people [1] . AKU is caused by deficiency of homogentisate 1,2-dioxygenase (HGD) activity in the liver [2] , since the gene for HGD is mutated in AKU patients [3, 4] . The lack of HGD activity leads to elevated levels of homogentisic acid (HGA), which is an intermediary product of tyrosine metabolism. Excess HGA is excreted daily in the urine, giving a black colour after oxidation [5] . This colouration is the first and best-known manifestation of the disease. Some evidence suggests that it is not HGA itself but a byproduct of its oxidation, a benzoquinone acetic acid, that can polymerize to a melanin-like pigment by unknown mechanisms and accumulates both inter-and intracellularly in connective tissue, most commonly the joints, cardiovascular system, kidney, skin and glands [2, 4, 6, 7, 8] , a pathological condition known as ochronosis. The major clinical manifestations of AKU usually become evident in the fourth or fifth decade of life and are related to deposition of ochronotic pigment in affected tissues. One of the most important complications of AKU is ochronotic arthropathy caused by polymer deposition in cartilage.
Several reports suggest that the first site of pigmentation is the chondrocyte but others have noted that pigment deposition occurs mainly in the ECM [9] . The reason for the affinity of ochronotic pigment to connective tissue is not known, but the pigment seems to have a particular affinity for fibrillar collagens that are surrounded by mucopolysaccharide ground substance.
To date, there is still no effective treatment for AKU. Dietary modifications to restrict intake of tyrosine and phenylalanine have been met with limited success owing to the difficulty in maintaining such a restrictive diet for the whole of a person's life. There is some indication that ascorbic acid might have a protective effect, but results have been variable [10, 11] . More recently, nitisinone, a potent inhibitor of the enzyme responsible for converting hydroxyphenylpyruvate to HGA, has also been evaluated [12, 13] . Nitisinone has been shown to significantly lower the urinary excretion of HGA in both murine models and humans but there are no clinical trial data suggesting efficacy in long-term therapy [14] .
There are major limitations in studying the ochronosis of AKU. It is a rare disease and pigment deposition in AKU subjects occurs over a long time course. Although HGDdeficient mice exist, they do not normally develop ochronosis. Hence, to investigate the mechanism of formation of ochronotic pigment and to determine how the deposition of pigment in collagenous matrix leads to arthropathy, we have developed an in vitro model of ochronosis using osteosarcoma cell lines cultured for extended periods in medium containing HGA, at concentrations that include the range observed in the plasma of AKU patients in vivo. This in vitro model could contribute to a general understanding of the mechanism of ochronotic pigment deposition, the aetiology of the resulting arthropathies and to the development of strategies for preventing ochronosis.
Materials and methods

Materials
All reagents including HGA were obtained from SigmaAldrich (Dorset UK) unless otherwise stated.
Tissue histology
Tissues were obtained from a patient with AKU at the time of surgery with informed patient consent and with ethical approval from Liverpool Research Ethics Committee. Tissues were fixed in 10% phosphate buffered formol saline (PBFS), processed by routine paraffin embedding, sectioned at 5 mm and stained with nuclear fast red or Schmorl's reagent [15] .
Cell culture
Osteosarcoma cell lines (SaOS-2, MG63 and TE85) from laboratory stocks were cultured routinely in 9-cm Petri dishes containing DMEM supplemented with 10% fetal calf serum, 50 mg/ml of streptomycin, 50 U/ml of penicillin and 2 mM of L-glutamine (Invitrogen, Paisley, UK). The cells were maintained at 37 C in a humidified atmosphere of 93% air and 7% CO 2 .
Identification and quantitation of ochronotic pigment deposition in vitro
For experiments in which the deposition of ochronotic pigment was studied, cells were passaged at 4 Â 10 4 cells/ well into 24-well plates containing 13-mm diameter sterile coverslips and allowed to grow to confluence for periods up to 28 days with medium change every 3 days. Medium was supplemented with different concentrations of HGA from 033 mM to 0.33 mM. At the end of the incubation period, coverslips were washed briefly in isotonic saline solution, fixed in 10% PBFS and stained with Schmorl's stain for 5 min. They were rinsed in distilled water and counterstained in nuclear fast red for 5 min, dehydrated and then mounted using DPX (SigmaAldrich). Pigmentation was quantified in two ways. First, individual pigment deposits were counted on digital images of Schmorl's stained cultures and expressed per unit area. Secondly, the area of pigmentation was determined by point counting, using a grid overlain on digital images, and expressed as a proportion of the total area of the cell cultures.
Transmission electron microscopy of HGA-treated cells MG63 cells were cultured in the absence or presence of 0.33 mM HGA for 21 days. At the end of this period, cells were washed briefly in isotonic saline solution and fixed with 4% paraformaldehyde and 2.5% glutaraldehyde. Cells were then stained with 1% aqueous osmium tetroxide, dehydrated through graded alcohols and embedded into resin (Agar 100, Agar Scientific, Stanstead, UK). Seventy-nanometre sections were cut using a Reichert Ultracut E and post-stained using uranyl acetate and lead citrate. Transmission electron microscopy (TEM) was performed using an FEI 120 kV Tecnai G2 Spirit BioTWIN (FEI Electron Microscopes, Cambridge, UK), and images were obtained using digital image capture with an SIS Megaview III camera (Olympus, Munster, Germany).
Influence of HGA on cell growth and viability MG63 cells were seeded into 6-well plates at a concentration of 4 Â 10 4 cells per well and grown for 10 days in 2 ml of medium supplemented with different concentrations of HGA from 0.1 mM to 1 mM. Medium was changed after 5 days. At the end of the experimental period, the medium was removed, cleared by centrifugation and stored at À80 C for later detection of P1NP, the amino-terminal pro-peptide of type 1 pro-collagen. Cell layers were washed, trypsinized and counted in disposable haemocytometers (Labtech International, East Sussex, UK). Trypan blue exclusion was used to determine viability.
Measurement of P1NP secretion P1NP in conditioned medium harvested at the end of the experimental period was assayed using an Elecsys 2010 two-site electro-chemiluminescence immunoassay (Roche, Lewes, UK) according to the manufacturer's instructions.
Statistical analysis
Statistical analysis was performed by analysis of variance using StatsDirect. Differences between groups were determined by Neuman-Keuls post-test.
Results
Schmorl's stain identifies intra-and extracellular ochronotic pigment in situ Ochrontic pigment deposits were detected as brown granules in the ECM and within fibroblasts in sections of joint capsule from the knee of a patient with AKU (Fig. 1A) . Staining with Schmorl's stain, which stained the ochronotic deposits dark blue-green, enhanced the contrast between pigmented and non-pigmented tissue (Fig. 1B) .
Ochronotic pigment is deposited in cultures of osteosarcoma cells exposed to HGA When cells from the osteosarcoma lines SaOS-2, MG63 and Te85 were grown in medium containing HGA, there was a dose-dependent darkening of the medium over the 3 days between medium changes, as seen in Fig. 2 . In the absence of cells, an equivalent change in colour took place over 3 weeks (data not shown), indicating that cellular activity accelerated pigment formation. Phasecontrast microscopy revealed that cells from all three lines tolerated concentrations of HGA up to 0.33 mM without any evidence of cell toxicity other than slightly reduced growth rate (Fig. 3A-F) . Even at 0.33 mM, cells eventually reached confluence, albeit over a longer time period. However, at 1.0 mM there was a major inhibition of cell growth and adhesion (Fig. 3G) . In all three cell lines, there was a deposition of ochronotic pigment in the cells and cell layers with concentrations of HGA from 33 mM to 0.33 mM. Pigment could be detected as dark deposits in phase contrast (data not shown) and was readily identifiable in fixed tissue following Schmorl's staining, as in Fig. 4B -D. Schmorl's stain did not stain untreated cultures (Fig. 4A) . Quantification of pigment revealed a doserelated increase in pigmentation, either in the number of deposits and/or the total area of pigmentation in the cells and associated matrix from 33 mM to 0.33 mM HGA (Fig. 5A and B) . Pigment was deposited in all three cell lines with the highest deposition in SaOS-2 cells and the lowest in TE85 (data not shown).
TEM reveals intra-and extracellular pigment in HGA-treated cell cultures TEM examination of MG63 cultures revealed typical cellular structures with an associated network of extracellular fibres. Ochronotic pigment was detected both intracellularly and extracellularly as numerous small electron-dense deposits. Extracellular pigment deposits were closely associated with the fibrillar structures (Fig. 6 ).
HGA inhibits cell growth of MG63 cells and viability
There was a dose-dependent inhibition of cell growth up to 0.33 mM HGA, and severe cell toxicity at 1 mM in MG63 cells. Representative results from one experiment are shown in Fig. 7 . At HGA concentrations of 0.1 mM, the growth rate of MG63 cells was still 70% of control; there was little evidence of cell toxicity and the cells would reach confluence, albeit slightly slower.
The effect of HGA on the synthesis of collagen Collagen synthesis, as determined by assay of secreted P1NP and normalized for cell number, increased on treatment with HGA up to 0.33 mM in MG63 cells (Fig. 8) . However, there was almost complete inhibition at 1 mM HGA.
Assay of P1NP in a 5-day conditioned culture medium revealed that TE85 secreted the most collagen of the three cell lines. The mean concentration of P1NP in the conditioned medium from confluent 6 wells after 5 days of culture was 150 mg/l for TE85 cells, compared with 120 mg/l for MG63 and 20 mg/l for SaOS-2 cells. 
Discussion
The aim of this research was to develop an in vitro model of ochronosis. Other researchers have grown connective tissue cells in HGA [16, 17] but there have been no previous reports of pigment deposition in vitro. In order to achieve this end, we had to find a technique that would allow the sensitive and reliable identification of ochronotic pigment in cell cultures. We found that ochronosis in tissue sections from patients with AKU, normally identified as brown granules in the extracellular matrix and within fibroblasts, could be enhanced by Schmorl's stain. This stain produced an intense blue-green colouration that significantly enhanced the contrast between pigmented and non-pigmented tissue. Colour development with Schmorl's stain is dependent on the reduction of ferricyanide to ferrocyanide, and in tissues is most commonly associated with melanin, emphasizing the structural similarities of ochronotic pigment and melanin. Schmorl's stain was subsequently shown to stain deposits in cultures of osteosarcoma cell lines grown in medium containing HGA. No pigmented deposits were detected in control cultures and the extent of deposition was related to the concentration of HGA indicating that the pigment in the cultures was probably derived from polymerization of HGA. Furthermore, no pigmentation was seen in HGA-supplemented medium not exposed to cells over the same time course, indicating that cellular activity was required for deposition of pigment. The pigment was present intracellularly and extracellularly in the cultures reflecting the observation in situ. The relationship between the intra-and extracellular pigmentation is not clear. Although cellular activity appears to be required for pigmentation, the deposition of pigment in the extracellular environment indicated that ECM domains can act as nucleation points for deposition, as previously suggested [17] . Pigment formation in cultures was observed over a range of HGA concentrations from 33 mM to 0.33 mM, which includes the range observed in AKU patients in vivo. However, the time course of deposition in vitro of a few days was very rapid compared with pigmentation in vivo, which occurs over many years, indicating that there are protective mechanisms in tissues that inhibit pigmentation in vivo. In tissues, ECM components are assembled into complex structures in which fibrous proteins, proteoglycans and glycosaminoglycans are associated. This complex association is not replicated exactly in vitro and it is likely that the factors that protect ECM from pigmentation in vivo are absent in vitro and thus pigmentation is accelerated. Modifying the culture conditions to produce an ECM that is resistant to pigmentation might provide strategies to prevent ochronosis in people with AKU.
Medium containing HGA darkened during the period between medium changes (3-5 days). Again, this was greatly accelerated by cellular activity. Medium with a similar range of concentrations of HGA, incubated at 37 C but not in contact with cells, took several weeks to darken to the same extent.
Pigment was deposited in all three cell lines with the highest deposition in SaOS-2 cells and the lowest in TE85. We used these osteosarcoma cell lines because they are known to secrete ECM components including type I collagen, but the matrix does not mineralize under the culture conditions employed. Within the three cell lines investigated here, pigmentation was greatest in SaOS-2 cell cultures, which have the lowest level of collagen synthesis, indicating that the amount of collagen is not the key factor determining the extent of pigmentation. Unpublished observations have confirmed differential capacity of cell types to induce ochronosis in vitro, with even more pigmentation observed in culture of primary chondrocytes and chondrocytic cell lines (Tinti et al., data not published; Taylor et al., data not published). Differences between cell lines reinforce the findings that cellular activity is required for pigment deposition. Furthermore, it might be possible to exploit these differences to identify the mechanism of pigmentation www.rheumatology.oxfordjournals.org and to determine therapeutic regimes to prevent ochronosis.
Ultrastructural examination of HGA-treated cultures confirmed the presence of ochronotic-like deposits within cells and associated with a network of extracellular fibres. We have previously observed ochronotic pigment in situ in stained, ultrathin sections of tissue as electron-dense shard-like structures found both intracelluarly and also connected to collagen fibres in the ECM [18] . The initial deposits in the ECM in vivo appear to be associated with the periodicity of the collagen fibres, indicating a nucleation-like process. In contrast, although extracellular fibres could be identified in vitro, their morphology was not well ordered and no periodicity was observed. Pigmentation in vivo is focal and progressive. Tissues appear to be protected from pigmentation and other factors are required for ochronosis to proceed. In contrast, the disorganized matrix produced in vitro does not appear to be protected and allows pigmentation readily.
Although HGA is clearly toxic at high doses, ochronotic pigment is laid down at concentrations of HGA where there is no evidence of cell toxicity. Furthermore, the presence of HGA in medium up to 0.33 mM increases the synthesis of collagen, when normalized for cell number. Thus, deposition of pigment does not appear to be dependent on cell toxicity or inhibitory effects on the rate of collagen synthesis. In summary, we have developed an in vitro model of ochronosis that should contribute to a general understanding of joint destruction in AKU and to the aetiology of OA. 
Rheumatology key messages
. An in vitro model of ochronosis has been developed. . Pigmentation in vitro is more rapid than in vivo indicating that tissues are normally protected from ochronosis. . Ochronosis requires cellular activity. 
